The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Open accessAbstract
Aberrant Hedgehog (Hh) pathway activation has been implicated in cancers of diverse tissues and organs, and the tumor growth-inhibiting effects of pathway antagonists in animal models have stimulated efforts to develop pathway antagonists for human therapeutic purposes. These efforts have focused largely on cyclopamine derivatives or other compounds that mimic cyclopamine action in binding to and antagonizing Smoothened, a membrane transductory component. We report here that arsenicals, in contrast, antagonize the Hh pathway by targeting Gli transcriptional effectors; in the short term, arsenic blocks Hh-induced ciliary accumulation of Gli2, the primary activator of Hh-dependent transcription, and with prolonged incubation arsenic reduces steady-state levels of Gli2. Arsenicals active in Hh pathway antagonism include arsenic trioxide (ATO), a curative agent in clinical use for acute promyelocytic leukemia (APL); in our studies, ATO inhibited growth of Hh pathway-driven medulloblastoma allografts derived from Ptch +/− p53 −/− mice within a range of serum levels comparable to those achieved in treatment of human APL. Arsenic thus could be tested rapidly as a therapeutic agent in malignant diseases associated with Hh pathway activation and could be particularly useful in such diseases that are inherently resistant or have acquired resistance to cyclopamine mimics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function
Chiang, C., Litingtung, Y., Lee, E., Young, K. E., Corden, J. L., Westphal, H., & Beachy, P. A. (1996) · Nature · doi:10.1038/383407a0 · Cited by 3,062
Self-citationHedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Neuronal specification in the spinal cord: inductive signals and transcriptional codes
Jessell, T. M. (2000) · Nature Reviews Genetics · doi:10.1038/35049541 · Cited by 2,089
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Vertebrate Smoothened functions at the primary cilium
Corbit, K. C., Aanstad, P., Singla, V., Norman, A. R., Stainier, D. Y. R., & Reiter, J. F. (2005) · Nature · doi:10.1038/nature04117 · Cited by 1,481 · cited 2×
“Pathway activation is triggered upon binding of Hh ligand to its receptor Patched (Ptch), thus relieving Ptch inhibition of the seven-transmembrane protein Smoothened (Smo), which in turn permits Smo activation and, in mammals, accumulation of Smo within the primary cilium (6, 7).”
BackgroundInhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
Chen, J. K., Taipale, J., Cooper, M. K., & Beachy, P. A. (2002) · Genes & Development · doi:10.1101/gad.1025302 · Cited by 1,465
Self-citationShen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Patched1 Regulates Hedgehog Signaling at the Primary Cilium
Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007) · Science · doi:10.1126/science.1139740 · Cited by 1,426
Activating Smoothened mutations in sporadic basal-cell carcinoma
Xie, J., Murone, M., Luoh, S.-M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C.-W., Hynes, M., Goddard, A., et al. (1998) · Nature · doi:10.1038/34201 · Cited by 1,334
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
Taipale, J., Chen, J. K., Cooper, M. K., Wang, B., Mann, R. K., Milenkovic, L., Scott, M. P., & Beachy, P. A. (2000) · Nature · doi:10.1038/35023008 · Cited by 1,311
Self-citationHedgehog: functions and mechanisms
Varjosalo, M., & Taipale, J. (2008) · Genes & Development · doi:10.1101/gad.1693608 · Cited by 1,217
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905360 · Cited by 1,109
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902903 · Cited by 1,019
Small molecule modulation of Smoothened activity
Chen, J. K., Taipale, J., Young, K. E., Maiti, T., & Beachy, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182542899 · Cited by 992
Self-citationA paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Zhao, C., Chen, A., Jamieson, C. H., Fereshteh, M., Abrahamsson, A., Blum, J., Kwon, H. Y., Kim, J., Chute, J. P., Rizzieri, D., et al. (2009) · Nature · doi:10.1038/nature07737 · Cited by 869
Self-citationTeratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
Cooper, M. K., Porter, J. A., Young, K. E., & Beachy, P. A. (1998) · Science · doi:10.1126/science.280.5369.1603 · Cited by 848
Self-citationSmoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Mutations in SUFU predispose to medulloblastoma
Taylor, M. D., Liu, L., Raffel, C., Hui, C.-C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., et al. (2002) · Nature Genetics · doi:10.1038/ng916 · Cited by 806
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
Self-citationArsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction
Incardona, J. P., Gaffield, W., Kapur, R. P., & Roelink, H. (1998) · Development · doi:10.1242/dev.125.18.3553 · Cited by 656
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Self-citationExpansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
Dierks, C., Beigi, R., Guo, G.-R., Zirlik, K., Stegert, M. R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.003 · Cited by 517
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Frank-Kamenetsky, M., Zhang, X. M., Bottega, S., Guicherit, O., Wichterle, H., Dudek, H., Bumcrot, D., Wang, F. Y., Jones, S., Shulok, J., et al. (2002) · Journal of Biology · doi:10.1186/1475-4924-1-10 · Cited by 488
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
Peacock, C. D., Wang, Q., Gesell, G. S., Corcoran-Schwartz, I. M., Jones, E., Kim, J., Devereux, W. L., Rhodes, J. T., Huff, C. A., Beachy, P. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611682104 · Cited by 478
Self-citationSvärd, J., Henricson, K. H., Persson-Lek, M., Rozell, B., Lauth, M., Bergström, Å., Ericson, J., Toftgård, R., & Teglund, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2005.12.013 · Cited by 468 · cited 1×
“These results suggest that arsenic acts within the Hh pathway at a point downstream of Smo, and we further examined this possibility by measuring pathway activity in Sufu mouse embryonic fibroblasts (MEFs) (50).”
BackgroundHedgehog beyond medulloblastoma and basal cell carcinoma
Teglund, S., & Toftgård, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.003 · Cited by 426
Tchounwou, P. B., Patlolla, A. K., & Centeno, J. A. (2003) · Toxicologic Pathology · doi:10.1080/01926230390242007 · Cited by 411
Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.29.3.1 · Cited by 407
Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis
Tian, H., Callahan, C. A., DuPree, K. J., Darbonne, W. C., Ahn, C. P., Scales, S. J., & de Sauvage, F. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813203106 · Cited by 404
GDC-0449—A potent inhibitor of the hedgehog pathway
Robarge, K. D., Brunton, S. A., Castanedo, G. M., Cui, Y., Dina, M. S., Goldsmith, R., Gould, S. E., Guichert, O., Gunzner, J. L., Halladay, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.049 · Cited by 386
Nolan-Stevaux, O., Lau, J., Truitt, M. L., Chu, G. C., Hebrok, M., Fernández-Zapico, M. E., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1753809 · Cited by 383
Chen, M.-H., Wilson, C. W., Li, Y.-J., Law, K. K. L., Lu, C.-S., Gacayan, R., Zhang, X., Hui, C.-C., & Chuang, P.-T. (2009) · Genes & Development · doi:10.1101/gad.1794109 · Cited by 353
Kim, J., Kato, M., & Beachy, P. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912180106 · Cited by 344
Self-citationCoamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib, Z. A., Matsushime, H., Valentine, M. B., Shapiro, D. N., Sherr, C. J., & Look, A. T. (1993) · PubMed · Cited by 338
Essential role of stromally induced hedgehog signaling in B-cell malignancies
Dierks, C., Grbic, J., Zirlik, K., Beigi, R., Englund, N. P., Guo, G.-R., Veelken, H., Engelhardt, M., Mertelsmann, R., Kelleher, J. F., et al. (2007) · Nature Medicine · doi:10.1038/nm1614 · Cited by 329
Ma, Y., Erkner, A., Gong, R., Yao, S., Taipale, J., Basler, K., & Beachy, P. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00977-7 · Cited by 327
Self-citationSmall-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
Hyman, J. M., Firestone, A. J., Heine, V. M., Zhao, Y., Ocasio, C. A., Han, K., Sun, M., Rack, P. G., Sinha, S., Wu, J. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907134106 · Cited by 305
Williams, J. A., Guicherit, O. M., Zaharian, B. I., Xu, Y., Chai, L., Wichterle, H., Kon, C., Gatchalian, C., Porter, J. A., Rubin, L. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0732813100 · Cited by 299
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Tremblay, M. R., Lescarbeau, A., Grogan, M. J., Tan, E., Lin, G., Austad, B. C., Yu, L.-C., Behnke, M. L., Nair, S. J., Hagel, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900305z · Cited by 252
Amplification of the gli gene in childhood sarcomas.
Roberts, W. M., Douglass, E., Peiper, S., Houghton, P. J., & Look, A. T. (1989) · PubMed · Cited by 246
Arsenic Trioxide: New Clinical Experience With an Old Medication in Hematologic Malignancies
Douer, D., & Tallman, M. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.217 · Cited by 236
The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity
Kitchin, K. T., & Wallace, K. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.10.021 · Cited by 233
Divergence of Hedgehog Signal Transduction Mechanism between Drosophila and Mammals
Varjosalo, M., Li, S.-P., & Taipale, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2005.12.014 · Cited by 230
Activation of the hedgehog pathway in advanced prostate cancer.
Mori, T., Doi, R., Koizumi, M., et al. (2004) · PubMed · doi:10.1186/1476-4598-3-29 · Cited by 221
Loss of suppressor-of-fused function promotes tumorigenesis
Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H. R., Curran, T., & McKinnon, P. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210467 · Cited by 218
A frequent activated smoothened mutation in sporadic basal cell carcinomas
Lam, C.-W., Xie, J., To, K.-F., Ng, H.-K., Lee, K.-C., Yuen, N. W.-F., Lim, P.-L., Chan, L. Y.-S., Tong, S.-F., & McCormick, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202360 · Cited by 202
Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics
Peukert, S., & Miller‐Moslin, K. (2010) · ChemMedChem · doi:10.1002/cmdc.201000011 · Cited by 177
An assessment of the developmental toxicity of inorganic arsenic
DeSesso, J., Jacobson, C., Scialli, A., Farr, C., & Holson, J. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00021-5 · Cited by 172
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., & Üren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806233200 · Cited by 170
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
Zwerner, J. P., Joo, J., Warner, K., Christensen, L., Hu‐Lieskovan, S., Triche, T. J., & May, W. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210991 · Cited by 135
Naturally Occurring Small‐Molecule Inhibitors of Hedgehog/GLI‐Mediated Transcription
Hosoya, T., Arai, M. A., Koyano, T., Kowithayakorn, T., & Ishibashi, M. (2008) · ChemBioChem · doi:10.1002/cbic.200700511 · Cited by 129
Kitchin, K. T., & Wallace, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.010 · Cited by 123
1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity
Miller, K. M., Peukert, S., Jain, R. K., McEwan, M. A., Karki, R., Llamas, L., Yusuff, N., He, F., Li, Y., Sun, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900309j · Cited by 104
Signal transduction pathways regulated by arsenate and arsenite
Porter, A. C., Fanger, G. R., & Vaillancourt, R. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203214 · Cited by 89
Giafis, N., Katsoulidis, E., Sassano, A., Tallman, M. S., Higgins, L. S., Nebreda, Á. R., Davis, R. J., & Platanias, L. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3699 · Cited by 80
Fei, D. L., Li, H., Kozul, C. D., Black, K. E., Singh, S., Gosse, J. A., DiRenzo, J., Martin, K. A., Wang, B., Hamilton, J. W., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2898 · Cited by 59
Arsenic trioxide decreases AKT protein in a caspase-dependent manner
Mann, K. K., Colombo, M., & Miller, W. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2164 · Cited by 47
Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide
Shackelford, D. B., Kenific, C. M., Blusztajn, A., Waxman, S., & Ren, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1774 · Cited by 46
The Imidazopyridine Derivative JK184 Reveals Dual Roles for Microtubules in Hedgehog Signaling
Cupido, T., Rack, P. D., Firestone, A. J., Hyman, J. M., Han, K., Sinha, S., Ocasio, C. A., & Chen, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805666 · Cited by 41
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Rimkus, T., Carpenter, R., Qasem, S., Chan, M., & Lo, H.-W. (2016) · Cancers · doi:10.3390/cancers8020022 · Cited by 581
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
The Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
Metadata
- Authors
- Kim, J., Lee, J. J., Kim, J., Gardner, D., & Beachy, P. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-07-12
- Volume
- 107
- Issue
- 30
- Pages
- 13432-13437
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027034464
- Cited by
- 304
- References
- 66
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.